Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524396 NSE: BIOFILCHEM Trading | Small Cap | Biofil Chem & Pharma Share Price
₹32.52 -0.34 (-1.03%)
As on 21-Sep'26 16:59
Biofil Chemicals & Pharmaceuticals Ltd (BIOFILCHEM)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524396 NSE: BIOFILCHEM Trading | Small Cap | Biofil Chem & Pharma Share Price
₹32.52 -0.34 (-1.03%)
As on 21-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹53 Cr.
Current Price
₹32.5
52-Week Low / High
₹26 / 47
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
39.7
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
-14.97%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
46.79%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹16.3 Cr.
Face Value
₹10
All Time Low / High
₹0.30 / 352.45
Check Before You Invest
M-Cap below 100cr DeciZen not available
Is Biofil Chemicals & Pharmaceuticals Ltd a good quality company?
Biofil Chemicals & Pharmaceuticals Ltd is a quality company, based on a multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Biofil Chemicals & Pharmaceuticals Ltd performance compare with that of its Peers?
Revenue growth of Biofil Chemicals & Pharmaceuticals Ltd vs industry peers?
Biofil Chemicals & Pharmaceuticals Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of Biofil Chemicals & Pharmaceuticals Ltd?
Promoters hold 46.79% of the Biofil Chemicals & Pharmaceuticals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Biofil Chemicals & Pharmaceuticals Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 16.4% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Biofil Chemicals & Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 26.2% | 7% | 6.8% | 13.3% | 15.8% | 8% | 6.1% | 6.3% | 5.1% | 19.1% | - |
| Value Creation Index ⓘ | 0.9 | -0.5 | -0.5 | -0.1 | 0.1 | -0.4 | -0.6 | -0.6 | -0.6 | 0.4 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 13.5 | 12.4 | 23.1 | 29.7 | 35.8 | 22.4 | 30 | 40 | 33.4 | 28.4 | 34 |
| Sales YoY Gr. | - | -8.1% | 87.1% | 28.4% | 20.4% | -37.4% | 34.2% | 33.3% | -16.6% | -15% | - |
| Adj EPS ⓘ | 1.1 | 0.3 | 0.3 | 0.7 | 0.8 | 0.4 | 0.3 | 0.4 | 0.3 | 0.5 | 0.3 |
| YoY Gr. | - | -73.6% | 3.5% | 146.7% | 2.7% | -43.4% | -20.9% | 29.4% | -22.7% | 47.1% | - |
| BVPS (₹) ⓘ | 5.5 | 5.8 | 6.1 | 6.8 | 7.6 | 8 | 8.3 | 8.9 | 9.2 | 10.9 | 11 |
| Adj Net Profit ⓘ | 1.8 | 0.5 | 0.5 | 1.2 | 1.2 | 0.7 | 0.6 | 0.7 | 0.6 | 0.8 | 0 |
| Cash Flow from Ops. ⓘ | 0.7 | 0.5 | 1.3 | 0.9 | 1.1 | -0.2 | -0.1 | 2.4 | -1.9 | -0.6 | - |
| Debt/CF from Ops. ⓘ | 2 | 3.4 | 1.3 | 1.3 | 0.4 | -2.1 | -4.7 | 0.2 | -0.3 | -5 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 8.7% | -4.5% | -1.9% | -15% | ||||
| Adj EPS ⓘ | -8.4% | -8% | 13.7% | 47.1% | ||||
| BVPSⓘ | 8% | 7.6% | 9.6% | 18.5% | ||||
| Share Price | 16.7% | -12.5% | -12.9% | -23.9% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 15.2 | 3.6 | 3.6 | 8.5 | 8 | 4.2 | 3.3 | 4 | 3 | 4.1 | 2.7 |
| Op. Profit Mgn % ⓘ | 19.5 | 7.6 | 4.4 | 6.1 | 4.5 | 6 | 3.9 | 2 | 2.5 | 2.3 | 2.3 |
| Net Profit Mgn % ⓘ | 13.3 | 3.8 | 2.1 | 4.1 | 3.5 | 3.1 | 1.9 | 1.8 | 1.7 | 2.9 | 1.4 |
| Debt to Equity ⓘ | 0.2 | 0.2 | 0.2 | 0.1 | 0 | 0 | 0 | 0 | 0 | 0.2 | - |
| Working Cap Days ⓘ | 371 | 397 | 223 | 282 | 281 | 262 | 192 | 267 | 429 | 482 | 187 |
| Cash Conv. Cycle ⓘ | 31 | 139 | 68 | 51 | 65 | 74 | 101 | 76 | 102 | 154 | 70 |
Valuation of Biofil Chem & Pharma - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Biofil Chemicals & Pharmaceuticals Ltd FAQs
The current trading price of Biofil Chem & Pharma on 21-Sep-2026 16:59 is ₹32.52.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 20-Sep-2026 the market cap of Biofil Chem & Pharma stood at ₹52.92 Cr
The latest P/E ratio of Biofil Chem & Pharma as of 20-Sep-2026 is 109.8.
The latest P/B ratio of Biofil Chem & Pharma as of 20-Sep-2026 is 2.95.
The 52-week high of Biofil Chem & Pharma is ₹46.82 and the 52-week low is ₹25.60.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Biofil Chem & Pharma is ₹34.31 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Biofil Chemicals & Pharmaceuticals Ltd is a below average quality company.
The key valuation ratios of Biofil Chemicals & Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Biofil Chemicals & Pharmaceuticals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About Biofil Chemicals & Pharmaceuticals Ltd
Biofil Chemicals & Pharmaceuticals established in 1985, is part of Cyano Group of Industries. The company is into manufacturing of drugs in area of anti-bacterial, analgesics/antipyretics, anti-malarial, anti-psychotics, anti asthmatic/bronchodilators, diuretics, tranquilizer/hypnotics, anti inflammatory, analgesic/antipyretics, anti inflammatory steroids and eye/ear drops
Its plant is located at Plot No. 8, Sector-IV Kheda Industrial Estate, Pithampur, Dhar District, Madhya Pradesh. The facility has received GMP certificate from Licensing Authority, Food & Drugs Administration, Department of Health and Government of Madhya Pradesh, India.
The manufacturing unit exports around 30 to 40% of their formulation directly or through merchant export to countries in own or neutral labels.
The shares of companies are listed on Bombay Stock Exchange.
Company exports its products to countries namely Kenya, Uganda, Tanzania, Nigeria, U.A.E, Rwanda, Monrovia, Republic of Yemen and Mauritius.
You have 47 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
